Directory

>

Meghan Miller

avatar

Meghan Miller

Executive Director, Translational Biomarkers | Skyhawk Therapeutics

Basel, Basel-City, Switzerland

View contact details (it's free)

Meghan Miller

Summary

Meghan Miller is an accomplished executive in the biotechnology field, currently serving as the Executive Director of Translational Biomarkers at Skyhawk Therapeutics in Basel, Switzerland. With a strong background in biochemistry and molecular biology, she has led significant advancements in biomarker discovery and translational research. Her previous roles at Roche involved leading research teams focused on rare diseases, where she successfully managed cross-functional collaborations and clinical development strategies. Meghan's educational foundation includes a PhD in Biomedical Sciences from UC San Diego, complemented by a BA in Mathematics from Colgate University. She is recognized for her ability to bridge scientific research with clinical applications, making her a key player in the commercial physical research industry. Her passion for innovation and patient-centered outcomes drives her commitment to advancing healthcare solutions. Outside of her professional endeavors, Meghan is likely to engage in community initiatives that promote science education and research accessibility.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Sustainability

Organisational experience

Corporate Experience

Meghan Miller

Work Experience

company logo

Executive Director, Translational Biomarkers at

Skyhawk Therapeutics

April 2024 - Present

company logo

Sr. Director, Discovery/Translational Biology at

Skyhawk Therapeutics

May 2023 - June 2024

company logo

Director, Discovery/Translational Biology at

Skyhawk Therapeutics

May 2021 - May 2023

company logo

Assoc. Director of Translational Biology, Neurobiology at

Skyhawk Therapeutics

September 2019 - May 2021

company logo

Head of Research, Rare Diseases at

Roche

February 2019 - August 2019

company logo

Senior Project Leader, Rare Diseases at

Roche

November 2017 - February 2019

company logo

Discovery Project Leader, Rare Diseases at

Roche

September 2015 - November 2017

company logo

Postdoctoral Research Associate at

Roche

February 2012 - August 2015

company logo

Postdoctoral Research Associate at

University Of California San Diego

January 2010 - January 2011

company logo

PhD student - Biomedical Sciences, Pharmacology at

University Of California San Diego

January 2004 - January 2010

company logo

HHMI Med-into-Grad Fellow at

University Of California San Diego

January 2008 - January 2008

company logo

Pre-IRTA Fellow at

The National Institutes of Health

January 2003 - January 2004

company logo

Pre-IRTA Fellow at

The National Institutes of Health

January 2002 - January 2003

Logos provided by Logo.dev

Meghan Miller

Education

UC San Diego School of Medicine, Phd

Frequently Asked Questions about Meghan Miller

What is Meghan Miller email address?

Meghan Miller's primary email address is ******@skyhawktx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Meghan Miller work for?

Meghan Miller is a Executive Director, Translational Biomarkers at Skyhawk Therapeutics, a company specializing in Commercial physical research.

Where Meghan Miller graduated from?

Meghan Miller holds a degree in Biomedical Sciences, Pharmacology from UC San Diego School of Medicine.

How can I directly contact Meghan Miller?

To contact Meghan Miller directly, you can use the email address ******@skyhawktx.com. Complete contact information is available upon registration with Muraena.

Who is Meghan Miller?

Meghan Miller is an accomplished executive in the biotechnology field, currently serving as the Executive Director of Translational Biomarkers at Skyhawk Therapeutics in Basel, Switzerland. With a strong background in biochemistry and molecular biology, she has led significant advancements in biomarker discovery and translational research. Her previous roles at Roche involved leading research teams focused on rare diseases, where she successfully managed cross-functional collaborations and clinical development strategies. Meghan's educational foundation includes a PhD in Biomedical Sciences from UC San Diego, complemented by a BA in Mathematics from Colgate University. She is recognized for her ability to bridge scientific research with clinical applications, making her a key player in the commercial physical research industry. Her passion for innovation and patient-centered outcomes drives her commitment to advancing healthcare solutions. Outside of her professional endeavors, Meghan is likely to engage in community initiatives that promote science education and research accessibility.

Meghan`s contact details

mail

******@skyhawktx.com

Colleagues

avatar
Sergey Paushkin

Chief Scientific Officer

avatar
Hasane Ratni

Vice-President, Chemistry, Skyhawk Therapeutics

avatar
Kyle Dow

Vice President Corporate Development

avatar
Botao Liu

Executive Director, Bioinformatics

avatar
Douglas Faller

Chief Medical Officer

avatar
Joseph Duffy

Senior Vice President Chemistry

avatar
John Mckeague

Senior Vice President Legal

avatar
Amparo Garcia Lopez

Executive Director Discovery Biology

View Contact details (it's free)
Request Profile Removal